Skip to main content

Guttmacher Institute

Donate Now

Highlights

  • Roe v. Wade in Peril
  • COVID-19 impact
  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics
  • Public-use data sets

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health
  • Perspectives on Sexual and Reproductive Health

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship

Search form

Good reproductive health policy starts with credible research

 

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email
Guttmacher Institute

Good reproductive health policy starts with credible research

 

Donate Now

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email

Highlights

  • Roe v. Wade in Peril
  • COVID-19 impact
  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics
  • Public-use data sets

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health
  • Perspectives on Sexual and Reproductive Health

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship

Search form

Global

HIV & STIs

The Guttmacher Institute’s international work on HIV and other STIs focuses on developing regions. Our research and advocacy efforts have focused on the linkages between HIV and sexual and reproductive health and rights, the impact of STIs on maternal and newborn health, the need for new technologies (including multipurpose prevention technologies) and U.S. support for global AIDS programs. 

  • Fact Sheet

    Investing in Sexual and Reproductive Health in Low- and Middle-Income Countries

  • Policy Analysis

    The COVID-19 Outbreak: Potential Fallout for Sexual and Reproductive Health and Rights

  • Policy Analysis

    Just $10 Per Person a Year Could Provide Sexual and Reproductive Health Services to All—Will the United States Help Make That Happen?

Top Facts & Statistics

  • 1.5M

    women living with HIV become pregnant each year worldwide
  • $1.00

    the annual per capita cost to meet the need for essential adolescent sexual and reproductive health services
  • 1 in 3

    pregnant women in the developing world living with HIV receive no antiretroviral medication

Resources

  • December 2014 Fact Sheet

    Investing in Sexual and Reproductive Health in Latin America and the Caribbean

    Global

    • Contraception
    • HIV & STIs
    • Pregnancy
  • December 2014 Infographic

    Why invest in sexual and reproductive health in the developing world?

    Global

    • Contraception
    • HIV & STIs
    • Pregnancy
  • December 2014 Fact Sheet

    Vue d’ensemble : Les faits sur l’investissement dans la santé sexuelle et reproductive

    Global

    • Contraception
    • HIV & STIs
    • Pregnancy
  • December 2014 Fact Sheet

    Adding It Up: Investing in Sexual and Reproductive Health

    Global

    • Contraception
    • HIV & STIs
    • Pregnancy
  • December 2014 Fact Sheet

    Investing in Sexual and Reproductive Health in Asia

    Global

    • Contraception
    • HIV & STIs
    • Pregnancy
  • December 2014 Fact Sheet

    Haciendo cuentas: inversión en salud sexual y reproductiva

    Global

    • Contraception
    • HIV & STIs
    • Pregnancy
  • December 2014 Infographic

    Why invest in sexual and reproductive health in Sub-Saharan Africa?

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
  • November 2014 Infographic

    Pourquoi investir dans la santé sexuelle et reproductive en Afrique subsaharienne?

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
  • October 2014 News Release

    Multipurpose Prevention Technologies Could Significantly Boost Women’s Sexual and Reproductive Health

    Global

    • Contraception
    • HIV & STIs
  • October 2014 Policy Analysis

    Making the case for multipurpose prevention technologies: the socio-epidemiological rationale

    Heather D. Boonstra and Sneha Barot,BJOG: An International Journal of Obstetrics & Gynaecology

    Global

    • Contraception
    • HIV & STIs

Pages

  • « first
  • ‹ previous
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • next ›
  • last »
Explore the Data Center

Hear From An Expert

Supporting and adequately funding the development of multipurpose prevention technologies (MPTs) should be a higher priority for the U.S. government, especially at a time when private sector support is missing. Unfortunately, current funding—while critical in advancing this important work to date—has not been sufficient. This inadequate funding may significantly hamper the timely development of MPTs that could be a huge boost to achieving U.S. global health priorities

Heather D. Boonstra

Vice President for Public Policy

Select a country profile

Guttmacher Institute
Reproductive rights are under attack. Will you help us fight back with facts?
Donate Now
Follow Guttmacher:

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Footer Menu

  • Privacy Policy
© 2022 Guttmacher Institute. The Guttmacher Institute is registered as a 501(c)(3) nonprofit organization under the tax identification number 13-2890727. Contributions are tax deductible to the fullest extent allowable.

Get Our Updates